Searched for
ZYDUS CADILA
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Right pricing to hold the key for Zydus Cadila's vaccine launchZydus Cadila has the drug regulator's emergency use authorisation to administer its Covid vaccine, ZyCoV-D, in children aged 12-18 years. A...
- Zydus Cadila gets USFDA tentative nod for epilepsy treatment drugZydus Cadila has received tentative approval from the US Food and Drug Administration (USFDA) to market Brivaracetam tablets, in the streng...
- Zydus Cadila gets USFDA nod for antidepressant drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Nortriptyline Hydrochloride ...
- Zydus Cadila gets USFDA nod for thyroid drugZydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg,...
- Zydus Cadila completes phase 2 clinical trial in COVID-19 patients with biological therapy PegiHepIn a regulatory filing, Zydus Cadila said "it has successfully completed a phase 2 clinical trial in COVID-19 patients with its biological ...
- Zydus Cadila launches new product for COPD patients in IndiaDrug firm Zydus Cadila on Thursday said it is launching pressurized metered dose inhaler for patients suffering from Chronic Obstructive Pu...
- Zydus Cadila gets US health regulator nod for multiple sclerosis treatment drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Dimethyl Fumarate delayed re...
- Zydus Cadila gets tentative USFDA nod to market anti-cancer drugDrug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbocic...
- Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India"Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these ...
- Zydus Cadila set to bag Kraft Heinz portfolio for Rs 4600 crore, announcement likely on WednesdayET on October 11 had reported that Zydus Cadila is the frontrunner for the Kraft Heinz India portfolio. Zydus Cadila is the country’s fourt...
- Zydus Cadila gets USFDA nod for skin ointmentThe company has received final approval from the US Food and Drug Administration (USFDA) to market its product, Zydus Cadila said in a stat...
- Zydus Cadila gets USFDA nod for diabetes treatment drugZydus Cadila has received final approval from the US health regulator to market Nateglinide tablets, used for treatment of diabetes.
- Zydus Cadila gets USFDA approval for anti-viral drug AcyclovirPharmaceutical major Zydus Cadila has received final approval from United States Food & Drug Administration for marketing of Acyclovir.
- Zydus Cadila gets United States Food and Drug Administration nod for kidney stones tabletsZydus Cadila has received the final approval from the USFDA to market Potassium Citrate ER tablets in the strengths of 5 mEq, 10 mEq and 15...
- Zydus Cadila Group to merge its three subsidiaries with its listed entity Cadila Healthcare LtdIn 2000, Zydus Cadila had created a strategic alliance with Ambalal Sarabhai Enterprises to integrate the animal healthcare business of bot...
- Zydus Cadila concludes deal to re-launch Urokinase drugZydus Cadila concludes agreement with Canadian biotech company Microbix Biosystems to re-launch KINLYTIC, a life saving drug in North Ameri...
- Zydus Cadila to market Maxisal in India, Nepal: US firmUS-based Amarillo Bio-sciences Inc (ABI) today said Indian pharmaceutical major Zydus Cadila will be marketing its dietary supplement Maxis...
- Zydus Cadila in talks to market Bayer drugsAhmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...
Load More
